News | April 15, 2021
IMPCL revenue crosses Rs. 160 crore
Presently, IMPCL is manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for the various diseases spectrum
Presently, IMPCL is manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for the various diseases spectrum
GSKP announced sale of its newly constructed manufacturing plant at Vemgal, Karnataka to Hetero Labs for a cash consideration of Rs1.8bn
This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs
The company had filed a suit in the High Court of Justice, Ghana
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
The company has concluded our acquisition of Richcore Lifesciences on 20th Jan 2021.
Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.
Subscribe To Our Newsletter & Stay Updated
